Analysing the pharmacokinetics and pharmacodynamics of drugs in vivo by upgrading in vitro data based on mathematical modelling
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Florian Markowetz.
Experimental limitations as well as practical and ethical
aspects set a barrier to our ability to analyse the pharmacokinetics and
pharmacodynamics of drugs in vivo, in particular in human. In this talk,
we will show how a physiologically- & mechanism-based modelling
approach in combination with in vitro data can be used to analyse,
understand and optimize drug pharmacokinetics and effect in vivo. We
will illustrate how physiologically-based pharmacokinetic (PBPK) models
can be used to predict drug pharmacokinetics prior to any in vivo
experiment, how PBPK models, potentially evaluated and refined through
first in vivo experiments, can then be reduced to simple compartment
models representing essential PK characteristics of a drug, and how
single cell experiments, integrated into such compartment models, offer
the potential to elucidate and optimize drug action, in particular for
therapeutic protein drugs.
This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|